phrykt

Nkarta, Inc. (NKTX): who owns it and who trades it

As of Nov 16, 2026, NKTX insiders reported 3 open-market sales worth $70.4K and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Paul J Hastings (CEO), with $58.7K. 4 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Nkarta

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold. Funds mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns NKTX

136 funds and institutions reported NKTX shares worth $168M at the end of Q2 2026, about 83% of the company. The largest holder is Ra Capital Management, L.P. with 15.2%.

Funds and institutions (13F) 83%Everyone else 17%

10 largest owners, by share of the company

Ra Capital Management, L.P.15.2%
BlackRock, Inc.8.8%
NEA Management Company, LLC5.0%
Samsara Biocapital, LLC4.9%
SR One Capital Management, LP4.7%
GSK plc4.4%
Monaco Asset Management SAM3.3%
Vanguard Capital Management LLC3.1%
Citadel Advisors LLC3.1%
Two Sigma Investments, LP2.6%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Ra Capital Management, L.P.10.81M15.16%$30.6MNo change
BlackRock, Inc.6.30M8.84%$17.8M+40%
NEA Management Company, LLC3.57M5.01%$10.1MNo change
Samsara Biocapital, LLC3.51M4.92%$9.9MNo change
SR One Capital Management, LP3.33M4.68%$9.4MNo change
GSK plc3.15M4.42%$8.9MNo change
Monaco Asset Management SAM2.37M3.33%$6.7M-6%
Vanguard Capital Management LLC2.23M3.12%$6.3M+11%
Citadel Advisors LLC2.17M3.05%$6.2M+22%
Two Sigma Investments, LP1.87M2.63%$5.3M-9%
Wasatch Advisors LP1.58M2.21%$4.5MNo change
Acadian Asset Management LLC1.36M1.91%$3.8M+8%
State Street Corp1.29M1.80%$3.6M+4%
Geode Capital Management, LLC1.29M1.80%$3.6M+1%
Renaissance Technologies LLC1.18M1.65%$3.3M-32%
AQR Capital Management LLC1.05M1.48%$3M+77%
AWM Investment Company, Inc.906,0001.27%$2.6MNo change
Blackstone Inc.747,0441.05%$2.1M–
Marshall Wace, LLP673,0100.94%$1.9M–
Panagora Asset Management Inc583,2490.82%$1.7M+105%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, NKTX insiders reported $0 of open-market purchases and $70.4K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$0
0 trades, 0 people
Sales, 12 months
$70.4K
3 trades, 2 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Jun 18, 2026
Filed Jun 22, 2026

Purchases and sales by month

$65.6K$65.6KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Jun 18, 2026Paul J HastingsCEOSale1,776$2.71$4.8KForm 4
Jan 15, 2026Paul J HastingsCEOSale26,046$2.07$53.9KForm 4
Jan 15, 2026Nadir MahmoodPresidentSale5,649$2.07$11.7KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Paul J HastingsChief Executive Officer, Director–$58.7KJun 18, 2026
Nadir MahmoodPresident–$11.7KJan 15, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

NKTX short interest

Moderate short interest. 5.4% of NKTX shares are sold short: about 1 share in 19. Over the last 12 reports the number of shares short went down 26%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 3.84M NKTX shares were sold short, 5.4% of the shares outstanding, up 12.1% from the report before. At the average daily volume of 1.34M shares, buying them all back would take about 2.9 trading days (days to cover).

Shares short, % of all shares

5.36%May 15Oct 307.76%

Days to cover

2.9May 15Oct 3011.3

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20263.84M5.36%+12%1.34M2.9
Oct 15, 20263.42M4.78%-6%704,6704.9
Sep 30, 20263.66M5.11%+4%621,7385.9
Sep 15, 20263.51M4.90%+2%642,7185.5
Aug 31, 20263.44M4.80%-4%496,9636.9
Aug 14, 20263.60M5.02%+8%576,0186.2
Jul 31, 20263.33M4.67%+4%621,3285.3
Jul 15, 20263.20M4.49%-5%991,8723.2
Jun 30, 20263.38M4.74%-2%665,4795.1
Jun 15, 20263.46M4.85%-34%540,6476.4
May 29, 20265.23M7.33%+1%513,82810.2
May 15, 20265.16M7.24%-2%873,8755.9

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Nkarta company events

Nkarta filed 8 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 9, 2026.

  1. Nov 9, 2026AnnouncementThe Company announced initial clinical data from its ongoing Phase 1/2 Ntrust-2 basket study evaluating NKX019, its allogeneic, off-the-shelf, CD19-directed chimeric antigen receptor natural killer cell therapy candidate, in patients with idiopathic inflammatory myopathy and systemic sclerosis. Filing
  2. Nov 6, 2026AnnouncementShared information with investors. Filing
  3. Nov 5, 2026ResultsReleased financial results. Filing
  4. Aug 10, 2026ResultsReleased financial results. Filing
  5. Jun 11, 2026VoteReported shareholder vote results. Filing
  6. May 12, 2026ResultsReleased financial results. Filing
  7. Mar 26, 2026AnnouncementNkarta, Inc. entered into a Sales Agreement with Stifel, Nicolaus & Company, Incorporated with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of its common stock, par value $0.0001 per share, having an… Filing
  8. Mar 25, 2026ResultsReleased financial results. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Nkarta financials

Famous investors that hold NKTX

4 of the 50 well-known investors we track reported holding NKTX in their latest 13F filing. The largest position is Ken Griffin's, worth $4.5M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 20261.70M$4.5M0.0%-22%
Jim Simons · Renaissance TechnologiesQ3 2026799,319$2.1M0.0%-32%
Israel Englander · Millennium ManagementQ3 2026214,761$563K0.0%-34%
Steve Cohen · Point72 Asset ManagementQ3 2026137,054$359K0.0%+28%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Nkarta, Inc. (NKTX) stock

Who owns the most NKTX stock?

The largest reported owner of Nkarta, Inc. (NKTX) is Ra Capital Management, L.P., with 15.2% of the company. In total, 136 funds and institutions reported holding NKTX at the end of Q2 2026, together about 83% of the shares. See the largest owners.

Are NKTX insiders buying or selling?

In the last 12 months, NKTX insiders reported no open-market purchases and 3 sales worth $70.4K. The latest trade was on Jun 18, 2026. See every trade.

What is the short interest in NKTX?

As of Oct 30, 2026, 3.84M NKTX shares were sold short, 5.4% of the shares outstanding, up 12.1% from the report before. At the average daily volume of 1.34M shares, buying them all back would take about 2.9 trading days (days to cover). See the history.

Which famous investors hold NKTX?

4 of the 50 well-known investors we track reported NKTX in their latest 13F filing, including Ken Griffin, Jim Simons, Israel Englander. The largest position is worth $4.5M. See all holders.

Executive pay

Nkarta's chief executive was paid a total of $3M for the year ended Dec 31, 2025, down 25% from $4M the year before. In the last 12 months, Nkarta's executives and directors bought no stock on the open market and sold $70.4K.

Chief executive, total pay$3MYear ended Dec 31, 2025. Salary, bonus and the value of stock and option awards when granted.
Pay "actually paid"$2MThe same year, with stock awards valued at what they were worth as they vested or at year end.
Other top executives, average$1.3MThe other officers named in the proxy statement.

From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.